AAAAAA

   
Results: 1-25 |
Results: 25
Key factors in Alzheimer's disease: beta-amyloid precursor protein processing, metabolism and intraneuronal transport
Authors: Bayer, TA Wirths, O Majtenyi, K Hartmann, T Multhaup, G Beyreuther, K Czech, C
Citation: Ta. Bayer et al., Key factors in Alzheimer's disease: beta-amyloid precursor protein processing, metabolism and intraneuronal transport, BRAIN PATH, 11(1), 2001, pp. 1-11
Identification of amplified genes from SV40 large T antigen-induced rat PNET cell lines by subtractive cDNA analysis and radiation hybrid mapping
Authors: Weggen, S Preuss, U Pietsch, T Hilger, N Klawitz, I Scheidtmann, KH Wiestler, OD Bayer, TA
Citation: S. Weggen et al., Identification of amplified genes from SV40 large T antigen-induced rat PNET cell lines by subtractive cDNA analysis and radiation hybrid mapping, ONCOGENE, 20(16), 2001, pp. 2023-2031
Intraneuronal A beta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice
Authors: Wirths, O Multhaup, G Czech, C Blanchard, V Moussaoui, S Tremp, G Pradier, L Beyreuther, K Bayer, TA
Citation: O. Wirths et al., Intraneuronal A beta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice, NEUROSCI L, 306(1-2), 2001, pp. 116-120
Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of Alzheimer's disease
Authors: Scheuermann, S Hambsch, B Hesse, L Stumm, J Schmidt, C Beher, D Bayer, TA Beyreuther, K Multhaup, G
Citation: S. Scheuermann et al., Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of Alzheimer's disease, J BIOL CHEM, 276(36), 2001, pp. 33923-33929
Low frequency of SV40, JC and BK polyomavirus sequences in human medulloblastomas, meningiomas and ependymomas
Authors: Weggen, S Bayer, TA von Deimling, A Reifenberger, G von Schweinitz, D Wiestler, OD Pietsch, T
Citation: S. Weggen et al., Low frequency of SV40, JC and BK polyomavirus sequences in human medulloblastomas, meningiomas and ependymomas, BRAIN PATH, 10(1), 2000, pp. 85-92
Lewy body variant of Alzheimer's disease: alpha-synuclein in dystrophic neurites of A beta plaques
Authors: Wirths, O Weickert, S Majtenyi, K Havas, L Kahle, PJ Okochi, M Haass, C Multhaup, G Beyreuther, K Bayer, TA
Citation: O. Wirths et al., Lewy body variant of Alzheimer's disease: alpha-synuclein in dystrophic neurites of A beta plaques, NEUROREPORT, 11(17), 2000, pp. 3737-3741
Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study
Authors: Block, W Bayer, TA Tepest, R Traber, F Rietschel, M Muller, DJ Schulze, TG Honer, WG Maier, W Schild, HH Falkai, P
Citation: W. Block et al., Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study, NEUROSCI L, 289(2), 2000, pp. 147-151
Expression of matrix metalloproteinase-2 in glial and neuronal tumor cell lines: inverse correlation with proliferation rate
Authors: Thier, M Roeb, E Breuer, B Bayer, TA Halfter, H Weis, J
Citation: M. Thier et al., Expression of matrix metalloproteinase-2 in glial and neuronal tumor cell lines: inverse correlation with proliferation rate, CANCER LETT, 149(1-2), 2000, pp. 163-170
Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorder
Authors: Bayer, TA Schramm, M Feldmann, N Knable, MB Falkai, P
Citation: Ta. Bayer et al., Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorder, PROG NEUR-P, 24(6), 2000, pp. 881-888
Disturbed gyrification of the prefrontal region in male schizophrenic patients: A morphometric postmortem study
Authors: Vogeley, K Schneider-Axmann, T Pfeiffer, U Tepest, R Bayer, TA Bogerts, B Honer, WG Falkai, P
Citation: K. Vogeley et al., Disturbed gyrification of the prefrontal region in male schizophrenic patients: A morphometric postmortem study, AM J PSYCHI, 157(1), 2000, pp. 34-39
It all sticks together - the APP-related family of proteins and Alzheimer's disease
Authors: Bayer, TA Cappai, R Masters, CL Beyreuther, K Multhaup, G
Citation: Ta. Bayer et al., It all sticks together - the APP-related family of proteins and Alzheimer's disease, MOL PSYCHI, 4(6), 1999, pp. 524-528
Neural expression profile of alpha-synuclein in developing human cortex
Authors: Bayer, TA Jakala, P Hartmann, T Egensperger, R Buslei, R Falkai, P Beyreuther, K
Citation: Ta. Bayer et al., Neural expression profile of alpha-synuclein in developing human cortex, NEUROREPORT, 10(13), 1999, pp. 2799-2803
Neural expression profile of Elav-like genes in human brain
Authors: Schramm, M Falkai, P Pietsch, T Neidt, I Egensperger, R Bayer, TA
Citation: M. Schramm et al., Neural expression profile of Elav-like genes in human brain, CLIN NEUR, 18(1), 1999, pp. 17-22
A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease
Authors: Papassotiropoulos, A Bagli, M Jessen, F Bayer, TA Maier, W Rao, ML Heun, R
Citation: A. Papassotiropoulos et al., A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease, ANN NEUROL, 45(5), 1999, pp. 666-668
Analysis of presenilin 1 and presenilin 2 expression and processing by newly developed monoclonal antibodies
Authors: Diehlmann, A Ida, N Weggen, S Grunberg, J Haass, C Masters, CL Bayer, TA Beyreuther, K
Citation: A. Diehlmann et al., Analysis of presenilin 1 and presenilin 2 expression and processing by newly developed monoclonal antibodies, J NEUROSC R, 56(4), 1999, pp. 405-419
No evidence for astrogliosis in brains of schizophrenic patients. A post-mortem study
Authors: Falkai, P Honer, WG David, S Bogerts, B Majtenyi, C Bayer, TA
Citation: P. Falkai et al., No evidence for astrogliosis in brains of schizophrenic patients. A post-mortem study, NEUROP AP N, 25(1), 1999, pp. 48-53
Evidence for activation of microglia in patients with psychiatric illnesses
Authors: Bayer, TA Buslei, R Havas, L Falkai, P
Citation: Ta. Bayer et al., Evidence for activation of microglia in patients with psychiatric illnesses, NEUROSCI L, 271(2), 1999, pp. 126-128
alpha-Synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores
Authors: Bayer, TA Jakala, P Hartmann, T Havas, L McLean, C Culvenor, JG Li, QX Masters, CL Falkai, P Beyreuther, K
Citation: Ta. Bayer et al., alpha-Synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores, NEUROSCI L, 266(3), 1999, pp. 213-216
Stability of RNA transcripts in post-mortem psychiatric brains
Authors: Schramm, M Falkai, P Tepest, R Schneider-Axmann, T Przkora, R Waha, A Pietsch, T Bonte, W Bayer, TA
Citation: M. Schramm et al., Stability of RNA transcripts in post-mortem psychiatric brains, J NEURAL TR, 106(3-4), 1999, pp. 329-335
Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the "Two hit hypothesis"
Authors: Bayer, TA Falkai, P Maier, W
Citation: Ta. Bayer et al., Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the "Two hit hypothesis", J PSYCH RES, 33(6), 1999, pp. 543-548
Increased oncogenicity of subclones of SV40 large T-induced neuroectodermal tumor cell lines after loss of large T expression and concomitant mutation in p53
Authors: Salewski, H Bayer, TA Eidhoff, U Preuss, U Weggen, S Scheidtmann, KH
Citation: H. Salewski et al., Increased oncogenicity of subclones of SV40 large T-induced neuroectodermal tumor cell lines after loss of large T expression and concomitant mutation in p53, CANCER RES, 59(8), 1999, pp. 1980-1986
Migratory potential of transplantable neural tumor cell lines
Authors: Bayer, TA Thier, M Roeb, E Breuer, B Weggen, S Wiestler, OD Weis, J
Citation: Ta. Bayer et al., Migratory potential of transplantable neural tumor cell lines, ACT NEUROP, 97(6), 1999, pp. 607-612
Reverse relationship between beta-amyloid precursor protein and beta-amyloid peptide plaques in Down's syndrome versus sporadic/familial Alzheimer's disease
Authors: Egensperger, R Weggen, S Ida, N Multhaup, G Schnabel, R Beyreuther, K Bayer, TA
Citation: R. Egensperger et al., Reverse relationship between beta-amyloid precursor protein and beta-amyloid peptide plaques in Down's syndrome versus sporadic/familial Alzheimer's disease, ACT NEUROP, 97(2), 1999, pp. 113-118
Analysis of a polymorphism in the tuberous sclerosis (TSC2) gene does not predispose to schizophrenia
Authors: Przkora, R Falkai, P von Deimling, A Wiestler, OD Albus, M Rietschel, M Maier, V Bayer, TA
Citation: R. Przkora et al., Analysis of a polymorphism in the tuberous sclerosis (TSC2) gene does not predispose to schizophrenia, EUR ARCH PS, 248(6), 1998, pp. 314-315
Reduced tyrosine kinase receptor C mRNA levels in the frontal cortex of patients with schizophrenia
Authors: Schramm, M Falkai, P Feldmann, N Knable, MB Bayer, TA
Citation: M. Schramm et al., Reduced tyrosine kinase receptor C mRNA levels in the frontal cortex of patients with schizophrenia, NEUROSCI L, 257(2), 1998, pp. 65-68
Risultati: 1-25 |